United Orthopedic Asset Resilience Ratio
United Orthopedic asset resilience ratio. United Orthopedic (4129) has an Asset Resilience Ratio of 0.13% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4129 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of United Orthopedic (2020–2024)
Asset resilience ratio of United Orthopedic from 2020 to 2024. This chart shows how United Orthopedic's Asset Resilience Ratio has changed over time. Read total liabilities of United Orthopedic for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down United Orthopedic's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see United Orthopedic assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$9.01 Million | 0.13% |
| Total Liquid Assets | NT$9.01 Million | 0.13% |
Asset Resilience Insights
- Limited Liquidity: United Orthopedic maintains only 0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
United Orthopedic Industry Peers by Asset Resilience Ratio
Compare United Orthopedic's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
United Orthopedic Asset Resilience Ratio by Year (2020–2024)
United Orthopedic asset resilience ratio by year from 2020 to 2024. The table below shows the annual Asset Resilience Ratio data for United Orthopedic.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.13% | NT$9.01 Million ≈ $283.71K |
NT$7.04 Billion ≈ $221.78 Million |
-0.01pp |
| 2023-12-31 | 0.14% | NT$8.89 Million ≈ $279.99K |
NT$6.42 Billion ≈ $202.17 Million |
-0.10pp |
| 2022-12-31 | 0.24% | NT$13.40 Million ≈ $422.21K |
NT$5.62 Billion ≈ $176.92 Million |
-0.27pp |
| 2020-12-31 | 0.51% | NT$28.45 Million ≈ $896.43K |
NT$5.59 Billion ≈ $176.03 Million |
-- |
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee… Read more